Sökning: "Neural Progenitor Cell"
Visar resultat 41 - 45 av 135 avhandlingar innehållade orden Neural Progenitor Cell.
41. Use of neural progenitor cell lines and astrocytes for transplantation and gene transfer to the CNS
Sammanfattning : Intracerebral neuronal transplantation have been shown to ameliorate symptoms of brain dysfunction in both animals models and Parkinson's disease, although problems still remain. The newly introduced technique of ex vivo gene transfer could serve as an alternative approach, possible avoiding some of the draw-backs of the embryonal tissue used in neuronal grafting. LÄS MER
42. Investigating the role of neural stem/progenitor regulators in the context of brain tumor development
Sammanfattning : Adult neural stem/progenitor cells (NSPs) are multipotent and self-renew over an extensive period of time. Transformation events in such cells, such as genetic or epigenetic alterations can result in brain tumors. LÄS MER
43. Host responses to human neural cell therapy in spinal cord injury
Sammanfattning : Spinal cord injury (SCI) is a devastating condition without a cure. The SCI process comprises an initially mechanical trauma and a secondary cascade of events including a robust inflammatory and immune response. LÄS MER
44. Neural stem cell therapy and inflammation status of post-traumatic syringomyelia
Sammanfattning : Post-traumatic syringomyelia (PTS) is a severe complication of chronic spinal cord injury (SCI) with intraspinal expanding cysts as the major pathology. PTS occurs in up to 30 % of SCI patients, and time of diagnosis is usually years after the primary injury. LÄS MER
45. Ionic modulators of stem cell state
Sammanfattning : Tissue generation during development and maintenance throughout life relies on the proliferation and sequential specification of a group of cells. Stem cells are defined by the properties of self-renewal (division to produce daughter cells equipotent to the mother) and differentiation (division where at least one daughter is of a more restricted potential). LÄS MER